Age-Associated Changes in Monocyte and Innate Immune Activation Markers Occur More Rapidly in HIV Infected Women

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Martin, Genevieve E ^a,b   Gouillou, Maelenn ^a   Hearps, Anna C ^a,b   Angelovich, Thomas A ^a,c   Cheng, Allen C ^b,d   Lynch, Fiona ^e   Cheng, Wan Jung ^a   Paukovics, Geza ^a   Palmer, Clovis S ^a,f   Novak, Richard M ^e   Jaworowski, Anthony ^a,b   Landay, Alan L ^g   Crowe, Suzanne M ^a,b,d  

^a BURNET INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c RMIT UNIVERSITY   (Australia)

^d ALFRED HOSPITAL   (Australia)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD14 ANTIGEN; CD163 ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; NEOPTERIN; SOLUBLE CD14 ANTIGEN; SOLUBLE CD163 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGING; ARTICLE; CD16+ MONOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE AGING; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; MONOCYTE; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGING; ANTIGENS, CD; ANTIGENS, CD14; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CXCL10; CROSS-SECTIONAL STUDIES; FEMALE; GPI-LINKED PROTEINS; HIV; HIV INFECTIONS; HUMANS; IMMUNITY, INNATE; IMMUNOPHENOTYPING; MIDDLE AGED; MONOCYTES; NEOPTERIN; RECEPTORS, CELL SURFACE; RECEPTORS, IGG;

EID: 84872850626     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055279     Document Type: Article

References (40)

1. Triant VA, Lee H, Hadigan C, Grinspoon SK, (2007) Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 92: 2506-2512.
2. Brown TT, Qaqish RB, (2006) Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 20: 2165-2174.
3. Desquilbet L, Jacobson LP, Fried LP, Phair JP, Jamieson BD, et al. (2007) HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci 62: 1279-1286.
4. Brew BJ, Crowe SM, Landay A, Cysique LA, Guillemin G, (2009) Neurodegeneration and ageing in the HAART era. J Neuroimmune Pharmacol 4: 163-174.
5. Cauley J, Danielson M, Boudreau R, Forrest K, Zmuda J, et al. (2007) Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J Bone Miner Res 22: 1088-1095.
6. Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, et al. (2008) Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 5: e78.
7. Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti MC, et al. (1999) Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 47: 639-646.
8. Keating SM, Golub ET, Nowicki M, Young M, Anastos K, et al. (2011) The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of US women. AIDS 25: 1823-1832.
9. Olsson J, Wikby A, Johansson B, Löfgren S, Nilsson B-O, et al. (2000) Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 121: 187-201.
10. Son NH, Murray S, Yanovski J, Hodes RJ, Weng N, (2000) Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age. J Immunol 165: 1191-1196.
11. Cao W, Jamieson BD, Hultin LE, Hultin PM, Effros RB, et al. (2009) Premature aging of T cells is associated with faster HIV-1 disease progression. J Acquir Immune Defic Syndr 50: 137-147.
12. Kaplan RC, Sinclair E, Landay AL, Lurain N, Sharrett AR, et al. (2011) T Cell Activation and Senescence Predict Subclinical Carotid Artery Disease in HIV-Infected Women. J Infect Dis 203: 452-463.
13. Belge K-U, Dayyani F, Horelt A, Siedlar M, Frankenberger M, et al. (2002) The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 168: 3536-3542.
14. Hearps AC, Martin GE, Angelovich TA, Cheng W-J, Maisa A, et al. (2012) Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging Cell 11: 867-875.
15. Nyugen J, Agrawal S, Gollapudi S, Gupta S, (2010) Impaired functions of peripheral blood monocyte subpopulations in aged humans. J Clin Immunol 30: 806-813.
16. Seidler S, Zimmermann HW, Bartneck M, Trautwein C, Tacke F, (2010) Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults. BMC Immunol 11: 30.
17. Hearps AC, Maisa A, Cheng W-J, Angelovich TA, Lichtfuss GF, et al. (2012) HIV infection induces age-related changes to monocytes and innate immune activation in young males which persist despite cART. AIDS 26: 843-853.
18. Thieblemont N, Weiss L, Sadeghi HM, Estcourt C, Haeffner-Cavaillon N, (1995) CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur J Immunol 25: 3418-3424.
19. Burdo TH, Lo J, Abbara S, Wei J, DeLelys ME, et al. (2011) Soluble CD163, a Novel Marker of Activated Macrophages, Is Elevated and Associated With Noncalcified Coronary Plaque in HIV-Infected Patients. J Infect Dis 204: 1227-1236.
20. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371.
21. Kamat A, Misra V, Cassol E, Ancuta P, Yan Z, et al. (2012) A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy. PLoS One 7: e30881.
22. Melmed RN, Taylor JM, Detels R, Bozorgmehri M, Fahey JL, (1989) Serum neopterin changes in HIV-infected subjects: indicator of significant pathology, CD4 T cell changes, and the development of AIDS. J Acquir Immune Defic Syndr 2: 70-76.
23. Heimbeck I, Hofer TP, Eder C, Wright AK, Frankenberger M, et al. (2010) Standardized single-platform assay for human monocyte subpopulations: Lower CD14+CD16++ monocytes in females. Cytometry A 77: 823-830.
24. Goetzl EJ, Huang MC, Kon J, Patel K, Schwartz JB, et al. (2010) Gender specificity of altered human immune cytokine profiles in aging. FASEB J 24: 3580-3589.
25. Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, et al. (2009) Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 15: 955-959.
26. Bell RJ, Lijovic M, Fradkin P, Davis SR, (2008) A pragmatic approach to the classification of menopausal status for community-based research. Menopause 15: 978-983.
27. Rothenbacher D, Muller-Scholze S, Herder C, Koenig W, Kolb H, (2006) Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers. Arterioscler Thromb Vasc Biol 26: 194-199.
28. Koten K, Hirohata S, Miyoshi T, Ogawa H, Usui S, et al. (2008) Serum interferon-gamma-inducible protein 10 level was increased in myocardial infarction patients, and negatively correlated with infarct size. Clin Biochem 41: 30-37.
29. Heller EA, Liu E, Tager AM, Yuan Q, Lin AY, et al. (2006) Chemokine CXCL10 Promotes Atherogenesis by Modulating the Local Balance of Effector and Regulatory T Cells. Circulation 113: 2301-2312.
30. Spencer ME, Jain A, Matteini A, Beamer BA, Wang NY, et al. (2010) Serum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI, and percentage of body fat. J Gerontol A Biol Sci Med Sci 65: 858-865.
31. Sandler NG, Wand H, Roque A, Law M, Nason MC, et al. (2011) Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 203: 780-790.
32. Bukh AR, Melchjorsen J, Offersen R, Jensen JM, Toft L, et al. (2011) Endotoxemia is associated with altered innate and adaptive immune responses in untreated HIV-1 infected individuals. PLoS One 6: e21275.
33. Wallet MA, Rodriguez CA, Yin L, Saporta S, Chinratanapisit S, et al. (2010) Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy. AIDS 24: 1281-1290.
34. Kitchens R, Thompson P, (2005) Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res 11: 225-229.
35. Kelesidis T, Kendall M, Yang O, Hodis H, Currier J, (2012) Biomarkers of microbial translocation and macrophage activation are associated with progression of subclinical atherosclerosis in HIV-1 infection. J Infect Dis 206: 1558-1567.
36. Romero-Sánchez M, González-Serna A, Pacheco YM, Ferrando-Martínez S, Machmach K, et al. (2012) Different biological significance of sCD14 and LPS in HIV-infection: Importance of the immunovirology stage and association with HIV-disease progression markers. J Infect 65: 431-438.
37. Prins M, Robertson JR, Brettle RP, Aguado IH, Broers B, et al. (1999) Do gender differences in CD4 cell counts matter? AIDS 13: 2361-2364.
38. Deeks SG, (2011) HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 62: 141-155.
39. Hearps AC, Angelovich TA, Jaworowski A, Mills J, Landay AL, et al. (2011) HIV infection and aging of the innate immune system. Sex Health 8: 453-464.
40. Kovacs A, Al-Harthi L, Christensen S, Mack W, Cohen M, et al. (2008) CD8+ T Cell Activation in Women Coinfected with Human Immunodeficiency Virus Type 1 and Hepatitis C Virus. J Infect Dis 197: 1402-1407.